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INTRODUCTION
Diabetes has been significantly widespread in Ukraine, 
especially in the last decade. There is an exceptionally 
rapid increase in its morbidity. [1, 2] The treatment of 
diabetes and its complications is an overwhelming task. 
In this regard, research and study of diabetes mellitus 
which makes it possible to identify the presence of a 
particular pharmacological activity of medicines or new 
parts in the mechanism of action of medicinal products, 
is important [3].
In recent days complex therapy in patients with this 
pathology has been complemented by a wide arsenal of 
physical methods of treatment. Hyperbaric oxygenation, 
quantum autohemotherapy, intrahistological electropho-
resis have been widely introduced into medical practice. 
The use of this complex of therapeutic measures in clinical 
practice, in case of purulent-destructive manifestations, 
points to the perspective for further research in this direc-
tion. Ozone therapy has been widely used for this purpose 
in recent years [4,5,6,7]. 
THE AIM
To study the influence of ozone in the complex treatment 
of patients with diabetes mellitus. 
MATERIALS AND METHODS
Main tasks and methods of research: the study of the course 
of purulent complications of diabetes mellitus when ozo-
notherapy is applied.
REVIEW AND DISCUSSION
Progressive course of pathological states, activated by 
insufficiency of endogenous insulin in the human body, 
affects the vascular, nervous and musculoskeletal systems. 
Disorders of endocrine-metabolic processes, which con-
sistently occur, lead to the tissue necrosis and the necessity 
of performing surgical interventions in this category of 
patients aimed at the removal of nonviable tissues [6,8].
Currently, in the aspect of the improvement of surgical 
care, research programs are aimed at fighting against severe 
purulent-necrotic lesions [7,9].
Pyoinflammatory diseases of soft tissues in patients with 
diabetes mellitus are a difficult problem of surgery. Hyperglyce-
mia, intoxication, disturbances of lipid peroxidation processes, 
antioxidant system and oxidative modification of proteins, 
microcirculatory exchange disorders contribute to the rapid 
spread of purulent processes with the development of a mutual 
burden syndrome. Consequently, the course of pyoinflamma-
tory processes of soft tissues in patients with diabetes needs 
further study in order to optimize its correction [8,10,11].
Integrated therapy of lesions is determined by their 
pathogenesis and stage of development. A steady com-
pensation of diabetes remains the basis for therapy and 
prevention [8]. In this case it is necessary to normalize not 
only glycemia, but also other types of exchange.
Active surgical sanation of purulent focus (wide opening, 
excision of necrotic tissues, active flow drainage) is the 
basis of tactics for inflammatory processes in soft tissues.
The results of the received literature data show that the 
use of physiotherapeutic methods of treatment provides 
significant help in achieving the positive effect of complex 
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treatment of purulent-necrotic complications in patients 
with diabetes [12,13,14].
Ozone used for therapeutic purposes is an ozone-oxygen 
mixture obtained from oxygen using a weak electrical discharge 
by means of medical ozone generators (ozonizers). The prin-
ciple of medical ozonizers action is as follows. Oxygen enters 
into two sequentially connected tubes that are under voltage of 
different power and form an electric field. Under the influence 
of a powerful electric field, a portion of the oxygen molecules 
are decomposed into atoms that react with other oxygen mol-
ecules and form ozone molecules. Depending on the voltage 
and velocity of the gas flow, a different concentration of ozone 
is achieved. The higher the voltage and the lower the flow rate, 
the higher the concentration of ozone is and vice versa.
To receive medical ozone it is necessary to supply the 
oxygen mixture only to pure (medical) oxygen to the 
ozonator. The use of less pure oxygen, and especially air, 
is unacceptable because of the presence of a large amount 
of nitrogen, which in the conditions of high voltage is con-
verted into toxic nitrogen oxide. For this purpose, ozone 
generators are equipped with destructors, where ozone ex-
cess is accumulated and regenerated again into oxygen [8].
In clinical practice, concentrations of ozone-oxygen mix-
tures at the outlet of an ozonizer in a wide range from 800 
μg/l [8] to 100000 μg/liter [8] are used for the preparation 
of the saline solution for intravenous administration.
After being prepared, the solution should be injected as 
soon as possible. This is due to the fact that ozone dissolves 
rapidly in the solution. According to Maslennikov O.V., 
the concentration of dissolved ozone in the saline solution 
at room temperature is reduced by 17% after 5 minutes, by 
29% after 10 minutes, by 37% after 15 minutes, by 43% after 
20 minutes, and twice after 30 min. It should be noted that 
nowadays there has been developed a device that allows 
stabilizing the concentration of dissolved ozone in the phys-
iological solution after barbotage during the infusion [7, 15].
The conducted complex research on the determination of 
the effectiveness of ozone therapy at the local and systemic 
application indicate its significant advantages compared 
with other physical methods of local and systemic effects 
on the metabolic, reparative, detoxification and sanation 
processes in the use of this type of treatment in patients 
with diabetes, complicated with pyoinflammatory pro-
cesses. It is proved that the systemic application of ozone 
significantly increases the permeability of cell membranes 
for glucose, due to the possibility of its direct stimulation 
of the pentosophosphate shunt and the activation of the 
processes of aerobic glycolysis, which is sharply suppressed 
in case of diabetes.
Clinical and experimental studies have found that ozone 
stimulation of pentosophosphate shunt and activation of 
aerobic glycolysis increase the production of glutathione, 
which participates in the synthesis of glycogen and fat from 
glucose and is involved in the synthesis of proteins. The sys-
temic application of ozone promotes complete oxidation of 
glucose to the final products of its decomposition, resulting 
in the restoration of its energy potential. Due to the active 
ozone action in case of DM, an adequate supply of energy 
needs of the body cells is provided and their functionality 
increases. Blocking of gluconeogenesis process (endogenous 
glucose formation from glycogen and proteins), which is 
realized under conditions of parenteral administration 
of ozonated solutions of 0.9% sodium chloride solution, 
reduces the rate of proteins decomposition and suppresses 
catabolic processes in the body of patients with DM. The 
level of lipid peroxidation is also reduced, which results in 
the normalization of the energy intensity of the body cells 
and the restoration of their functional activity [8,16].
The activation of glucose metabolism under the influence 
of ozone leads to the formation of 2,3-diphosphoglycerate in 
erythrocytes, which improves the oxygen-exchange function 
of red blood cells and eliminates hypoxic phenomena in the 
tissues of the body. A decrease in the level of glucosylated 
hemoglobin in erythrocytes of patients with diabetes has 
been confirmed, hence there is a significant improvement 
in the processes of releasing oxygen from erythrocytes and 
elimination of tissue hypoxia. On the basis of the results of 
laser fluometry, analysis of coagulogram, dynamics of malonic 
aldehyde and diene conjugates, the positive effect of ozono-
therapy on microcirculation and metabolic processes has 
been confirmed, along with lowering blood glucose, choles-
terol, triglycerides, accompanied with normalization of lipid 
peroxidation and increased activity of the antioxidant system 
of the organism. Reducing the level of hyperglycemia and 
normalizing the processes of absorption of glucose by body 
tissues, with a significant reduction in cell hypoxia, inhibits 
the rate of accumulation of sorbitol in the tissues of the body, 
preventing the development of macro- and microangiopathy. 
A similar dynamics of changes in metabolic transformations 
is observed in the study of the level of accumulation of gly-
cosaminoglycans, glucoproteins in the tissues that activate the 
process of angiopathy and arthropathy development [16, 17].
The use of systemic and local ozonotherapy in patients with 
pyoinflammatory complications concomitant with diabetes is 
perspective [6,7, 18]. Studies carried out in recent years have 
noted that under the conditions of a critical level of changes in 
metabolic processes in the body tissues caused by angiopathy, 
the development of purulent-necrotic processes in the presence 
of polymorphically associated microflora and intoxication of the 
organism, occurring in the result of it, large-scale autoimmune 
aggression, the combination of local and the overall healing 
effect of ozonotherapy has allowed to almost halve the time of 
cleansing the wound surface from purulent-necrotic masses 
and to trigger an early activation of regenerative processes [8, 
19]. The bacterio-, fungi-, and virucidal effects of ozone with 
the external use of its modifications, is explained by its oxidative 
influence on the membrane structures of bacteria and organ-
elles of bacterial cells. In turn, this results in the loss of their 
viability and reproductive capacity [19, 20].
The indirect effect of ozonolysis products is also signif-
icant in this aspect. When the effect of ozonolysis occurs 
the oxidative cytotoxic properties of formed ozonides, in 
direct interaction with lipid structures of the membrane of 
the bacterial cell, stimulate the development of secondary 
oxidative cytotoxic reactions, which have a detrimental 
effect on the viability of the bacterial cell [19].
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According to microbiological studies, ozone is capa-
ble of destroying all known types of gram-positive and 
gram-negative bacteria, in particular, the Pseudomonas 
aeruginosa, the legionella, all types of lipophilic and 
hydrophilic viruses, including hepatitis A, B, C viruses 
and spores of all known pathogenic fungi and protozoa. 
It has been confirmed that ozone concentrations of 1 to 
5 mg/l destroys 99.9% of E. coli, Streptococcus faecalis, 
Micobacterium tuberculosis, Cryptosporidium parvum, 
Varavium, and others within 4-20 minutes. At the ozone 
concentration of 0.1 mg/l with the time exposure 15-20 
minutes, the persistent spores of Penicillium notatum [10] 
are completely destroyed.
The confirmed antiviral effect of ozone on the culture of 
lymphocytes infected with HIV-1 [6,7,8,18] and the bacte-
ricidal effect of ozonized vegetable oil (oral dose – 5 to 10 
mg/l and for external use – 12 to 24 mg/l) caused by the 
presence of ozonides contained in it, formed as a result of 
the reaction of ozone with its carrier in the places of double 
bonds of fatty acid. At the expense of oxygen combinations 
of the ozone-unsaturated acid with the cellular envelope 
of body cells, a protective zone of their defense is formed, 
which further prevents the contact of the aggressive agent 
with the body cells [20].
An important biological effect observed in the systematic 
application of ozone therapy is the optimization of pro- 
and antioxidant systems in the body. It is noted that in 
response to the parenteral administration of ozone, there 
is a compensatory increase in the activity of antioxidant 
enzymes: superoxide dismutase, catalase and glutathione 
peroxidase in the tissues of the body. The activation of the 
enzyme and non-enzyme antioxidant systems of the body 
restores the activity of lipid peroxidation (LPO) process, 
activates metabolic reactions, with the help of which the 
precipitated NAD (nicotinamide adenine dinucleotide) 
and NADP (nicotinamide adenine dinucleotide phosphate) 
are accumulated in the Krebs cycle and the function of the 
pentose phosphate shunt is activated, the last is the protons 
donor for the restoration of the oxidative components of 
the non-enzyme antioxidant system (glutathione, vitamin 
E, ascorbic acid) [6,8].
Shubladze D.K. showed the effectiveness of local use of 
ozone in the treatment of purulent-necrotic complications 
in patients with diabetes, namely, the dynamics of wound 
healing, its epithelization, the number of bed-days spent 
in the hospital .
Gazin I.K. estimated the positive influence of methods of 
local ozonotherapy on the process of healing of purulent 
foot wounds in patients with diabetes mellitus.
Kantsaliyev L.B. used, along with the local application of 
ozone, the intravenous droplet administration of ozonized 
saline solution and showed that this method allows to reduce 
the volume of intervention, to reduce the frequency and vol-
ume of high amputations, and also to reduce the frequency 
of postoperative complications of the stump and to improve 
the quality of its preparation for orthopedic rehabilitation .
Tsariuk Yu.S. proved that the local effect of therapeutic ozone 
concentrations and ozone-containing medications possess ex-
tremely strong bactericidal, immunomodulatory, anti-inflam-
matory, virolytic, fungicidal, cytostatic, analgesic properties and 
open new prospects for the application of ozone in the treatment 
of pyoinflammatory complications in patients with diabetes.
The conducted studies on the use of ozonotherapy at 
the local and systemic application indicate its effective-
ness compared to other physical methods. Therapeutic 
concentrations of ozone (in a physiological solution from 
1 mg/l to 6 mg/l, on average 3-4 mg/l with a single dose 
of 1.2-1.6 mg) activate the immunomodulatory function 
of the body. When it is injected, on the membranes of 
phagocytic cells (leukocytes, monocytes, macrophages) 
hydrophilic compounds – ozonides are adsorbed, through 
which stimulation of cytokines in these cells is carried out, 
which, in their turn, promote activation of cellular and 
humoral immunity, which increases the level of nonspecific 
system of the organism protection.
CONCLUSIONS
Taking into account the above facts, it becomes obvious 
that it is necessary to seek for more effective and advanced 
methods of complex treatment of pyoinflammatory com-
plications of soft tissues, with an emphasis of search efforts 
on the introduction of effective therapeutic methods of 
conservative correction into the medical practice, methods 
of activation of reparative processes, aimed at restriction 
of invalidizating limb amputations, combined with further 
improvement of minimally invasive operational and tech-
nical innovations in the surgical direction.
Summarizing the review of literary sources, one can conclude 
that, despite a significant number of scientific papers devoted 
to the problem of pyoinflammatory complications of diabetes, 
there remain issues that require further study and solution.
    REFERENCES
 1.  Samyshkin Y., Guillermin A. Long-term cost-utility analysis of exenatide 
once weekly versus insulin glargine for the treatment of type 2 diabetes 
patients in the US. Journal of Medical Economics.  2012; 15: 6-13.
 2.  American Diabetes Association. Standarts of medical care in diabetes. 
Diabetes Care. 2014; 37:14-S80.
 3.   Germanyuk T.,  Ivko I. Rational choice of  monotherapy  for the treatment 
of  type 2 diabetes mellitus based o n  the  pharmacoeconomical analysis. 
Science Rise. 2014; 4 (5): 69-72.
 4.  Atkinson M., Herrath M., Powers A.C. at al.  Current concepts of the 
pathogenesis of type 1 diabetes — consi¬derations for attempts to 
prevent and reverse the disease .Diabetes Care. 2015; 38: 979-988.
 5.  Bolli G., De Vries J.H. New long-acting insulin analogs: from damp studies 
to clinical practice .  Diabetes Care. 2015; 38: 541-543.
  6.  Karatieieva S., Yurkiv O., Semenenko S. at al.   Evaluation of the use of 
ozone therapy in the treatment of inflammatory processes in diabetes 
mellitus in an experiment. Gorgian medical news. 2016;10(259): 58-61.
 7.  Karatieieva S., Plesh, I., Yurkiv O. at al.   New method of treatment of 
pyoinflammatory soft tissue complications in patients with diabetes 
mellitus . Gorgian medical news. 2017; 3(264): 58-60.
 8.  Karatieieva S.Yu. Zastosuvannia ozonoterapii z indyvidualnym 
pidborom dozy pry hniinykh protsessakh u khvorykh na tsukrovyi diabet 
.Bukovynskyi medychnyi visnyk. 2014; 4 (72): 43-44.
APPLICATION OF OZONE THERAPY IN SURGICAL PRACTICE
1079
 9.  Polovyi V., Fundiur V., Zheliba M. ta  inshi. Hniini protsesy miakykh 
tkanyn: etiolohiia, patohenez, likuvannia . Chernivtsi: 2013, s. 145- 200. 
 10.  Polovyi V.,  Fundiur V., Zheliba M. ta  inshi. Klinichna transfuziolohiia. 
Chastyna I. Antyhenni vlastyvosti krovi. Chernivtsi: 2014, s. 100 – 125. 
 11.  Hooshang M., Dale G., Faye W  . ABC Inventory Management Support 
System With a  Clinical Laboratory Application . Journal of Promotion 
Management. 2012 ;18: 414-435.
 12.  Kumar  S., Shakravarty  B.  ABC/VED  analysis  of  expendable  medical 
stores  atatertiary  carehospital. Medical  journal  armed  forces  india. 
2015; 71: 24-27.  
 13.  Beaudet  A., Palmer J., Timlin  L.  et al.  Cost-utility  of  exenatide  once 
weekly  compared  with  insulin  glargine  in  patients  with  type  2 
diabetes  in  the  UK. Journal of Medical Economics. 2011; 14: 357-366.
 14.  Andrews M., O’Malley P. Diabetes overtreatment in eldery individuals: risky 
business in need of better management .JAMA. 2014; 311: 2326-2327.
 15.   Giwa  A., Tayo F.  Sost-effectiveness  analysis  of  anti-diabetic  therapy  in 
a university teaching hospital. International Journal of Pharma Sciences 
and Research (IJPSR) .2014; 03:  82 - 91.
 16.   Mishchenko  O., Iakovlieva L.,  Adonkina  V. Pharmacoeconomic  evaluation 
of  fxed  –dose  triple combination for antihypertensive therapy in Ukraine. 
Journal of Health Policy Outcomes Research. 2014; 1: 66-74. 
 17.  Mpondo  B.  Glycaemic  control  and  glucose-lowering  therapy  in 
diabetic patients with kidney diseas. African Journal of Diabetes 
medicine. 2014; 1: 12-16.
 18.  Sharma P., Sharma  N.,  Parakh  R. et  al.  Screening of prescriptions 
in patients of type  – 2 diabetes mellitus in  a  tertiary  care  teaching 
hospital. International journal of pharmaceutical research and bio-
science. 2014; 3(1) : 401-409. 
 19.   Singh., Awadhesh  K. Deciding  oral  drugs  after  metformin in 
type  2 diabetes:  An  evidence based  approach.  Indian  Journal  of 
Endocrinology  & Metabolism. 2014; 5: 617.
 20.  Ahsen V. Avoiding hypoglycemia: a key to success for glucose – lowering 
therapy in type 2 diabetes . Vase. Healht. Risk. Man. 2013; 9: 155-163.
 
Authors’ contributions: 
According to the order of the Authorship.
Conflict of interest:
The Authors declare no conflict of interest.
CORRESPONDING AUTHOR
Svitlana Y. Karatieieva
Higher State Educational Institution of Ukraine 
“Bukovinian State Medical University”
Russka str. 229b/35, Chernivtsi, Ukraine
tel: +380662670935
e-mail: Karatsveta@gmail.com 
Received: 10.03.2018
Accepted: 15.07.2018
